Please login to the form below

Not currently logged in
Email:
Password:

difficult-to-treat cancers

This page shows the latest difficult-to-treat cancers news and features for those working in and with pharma, biotech and healthcare.

Tavros Therapeutics and Vividion Therapeutics collaborate in oncology programmes

Tavros Therapeutics and Vividion Therapeutics collaborate in oncology programmes

Tavros will receive $17.5m in a cash upfront payment from Vividion, according to the deal. ... undruggable. “We’re thrilled to launch our work with Vividion and harness our combined expertise to reach patients with difficult-to-treat cancers by

Latest news

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches

    Amgen Oncology, one of the leading developers of innovative therapies for novel targets in difficult-to-treat cancers, is working to bring new hope for transforming clinical outcomes for patients with ... Visit AmgenOncology.com to learn more about the

  • A snapshot of Crescendo Biologics A snapshot of Crescendo Biologics

    What is the central focus of Crescendo’s research? The company is focused on T-cell enhancement to develop new ways to treat difficult cancer types. ... success – or to make advances in those cancers that are still difficult to treat in this way.

  • Radiosurgery innovation

    Radiosurgery has greatest application in patients with difficult-to-treat cancers such as brain tumours. ... This was a tough ask of Pegasus as our technology is highly complex and it can be difficult to get journalists to understand its potential, let

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Wave Healthcare Communications

Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...

Latest intelligence

Actinic keratosis – a common skin condition that can lead to skin cancer
PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...